UCB Transformational Program Also
Honored
FAIRFIELD, N.J., Aug. 13, 2024 /PRNewswire/ -- To showcase the
impactful commitment and outcomes of equitable practices for women
in the workplace, the Healthcare Businesswomen's Association
(HBA) today announced that Takeda, Roche Genentech, a member of the
Roche Group, and UCB will be recognized for game-changing
initiatives to further the advancement and impact of women in the
healthcare and life science industries. The ACE Awards will be
presented on 24 September, in conjunction with the HBA's
25th Annual Conference in Toronto.
Healthcare Companies Recognized for
Advancing Women's Leadership Initiatives.
HBA's Advancement. Commitment. Engagement (ACE)
Awards recognize companies committed to ensuring that
leadership opportunities for women are part of their organizational
DNA. An independent panel of healthcare industry leaders selects
ACE Award recipients for their excellence in advancing their female
talent and removing the systemic barriers preventing timely
progress to parity. Award criteria include measurable results,
business performance, stewardship, execution, and
sustainability.
"As a United Force for Change, the HBA is honored to celebrate
these global industry champions for their conviction and
progressive approach to helping women reach their full potential
through their respective workplace initiatives," said Mary Stutts, CEO, HBA. "These programs align
with HBA's vision of advancing women into positions of influence
and decision-making that ultimately will help improve health equity
and outcomes for women around the world."
About the 2024 ACE Winners
Takeda: A Trailblazer in Gender Equity
Takeda, a leading, values-based R&D-driven global
biopharmaceutical company headquartered in Japan, is recognized for its pioneering Gender
Equity Strategy: "Paving the Way for a Diverse and Inclusive
Future."
Key achievements include:
- Increased Representation: As of the end of fiscal year
2023, female representation among senior most leaders increased to
46 percent (up 15 percent from fiscal year 2022). This increase
represents strong progress towards Takeda achieving their
aspiration to have 50 percent representation by female leaders
among our senior most leaders by the end of fiscal year 2027.
- Strategic Actions to Foster Inclusivity:
Cross-cultural leadership development, intentional focus on the
efforts of the gender parity employee resource group, and inclusive
benefits to meet the needs of underrepresented populations such as
LGBTQ+ and non-binary employees, directly addressing long-held
gender stereotypes.
- Talent Pipeline Development: Implementation of the HBA
Ambassador Program across Takeda's global locations, providing
development opportunities for underrepresented talent from entry-
to mid-levels of the organization.
Takeda embraces and celebrates diversity, while striving to give
patients and their people equitable access to opportunities that
help them achieve their full potential. Supporting gender parity,
this has placed Takeda in Equileap's 2024 Gender Equality Report
& Ranking in Japan for the
third consecutive year within the top 100 companies globally.
Roche and Genentech: Elevating Women's Healthcare
Worldwide
Introduced in 2023, the ACE Aspire Award is presented to Roche
and Genentech for their groundbreaking "Elevating Women's
Healthcare Around the World" program. This award honors
innovative, early-stage programs built on solid strategies and
metrics valuable to the healthcare ecosystem.
As a global leader in pharmaceuticals and diagnostics, Roche and
its U.S. affiliate Genentech partnered on the launch of this
transformative program in 2020 to address critical gaps in
care and improve access to medical innovations for women. Given
that women are the majority of the global healthcare workforce,
addressing and removing women's health barriers positively impacts
the health of all societies. Notable milestones include:
- Transforming Women's Health: Redefined women's health as
improving health outcomes for all conditions that predominantly,
exclusively, or differently affect women. Engaged global employees
and external collaborators to reshape health systems and advance
solutions across conditions, including multiple sclerosis and
breast, cervical, and lung cancers, among others.
- Catalyzing Meaningful Change: Created a collective
movement through XProject, a long-term commitment and ongoing
initiative to drive meaningful change through partnerships,
funding, and action to help close the gaps in women's health for
better health outcomes for everyone.
- Improving Health for Employees: Elevated the health of
women employees worldwide through training on self-advocacy,
awareness days, cancer and biometric screenings, wellness exams,
and pioneering menopause support in the U.S. and the U.K.
Roche and Genentech's commitment to women's health is driven by
senior leaders and bolstered by extensive collaborations, embedding
women's health across its business strategy and setting new
benchmarks for the industry.
UCB : A Decade of Transformational Impact
UCB receives an Honorable Mention for its "A Decade of
Transformational Impact with Women in Leadership (WiL) Employee
Resource Group (ERG)" program. As a global biopharmaceutical
company focused on creating valuable solutions that make
improvements to the lives of people living with neurological and
autoimmune conditions, UCB celebrates more than 10 years of its
Women in Leadership ERG.
Since its inception in 2012, the WiL has grown to more than 700
members globally, representing 16 percent of UCB's workforce. WiL
fosters diverse perspectives, driving innovation and agility within
UCB by contributing to corporate initiatives such as the company's
Women of Childbearing Age strategy. WiL's efforts have led to
improvements in gender diversity, including a 12 percent reduction
in the median gender pay gap in the U.K. since 2017.
The companies and initiatives recognized by HBA's ACE Awards
join an elite group of organizations committed to fostering
programs that deliver impactful and measurable results for industry
women. Throughout the year, the award-winning initiatives are
highlighted across HBA's extensive network. A list of previous ACE
Award recipients is available here.
About the Healthcare Businesswomen's Association:
The Healthcare Businesswomen's Association (HBA) is a
global organization dedicated to furthering the advancement and
impact of women in the business of healthcare. With
representation in countries across the globe, the HBA serves a
community of more than 85,000 individuals and 150 Corporate
Partners. The HBA provides networking forums to build
relationships; knowledge sharing and access to thought leaders to
broaden perspective; educational programs to develop leadership
skills; and high-profile industry recognition of outstanding women
and companies to promote visibility of their achievements.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/takeda-roche-and-genentech-recognized-by-the-healthcare-businesswomens-association-for-advancing-women-in-the-workplace-initiatives-302220956.html
SOURCE Healthcare Businesswomen's Association (HBA)